Ann: Improved Propofol TPM Formulation Passes Toxicology Study, page-16

I am interested in what the next steps in this process. Daptomycin is ready to go, Propofol has some more work but took a big step today. We knew that the propofol information was coming and was due around this time. What is the next key date?
I would suggest that it would seem AVE has something else in the pipeline in terms of Propofol. They mention how critical this is for licensing and it a similar phrase can be found in many recent announcements. Could this be a hint? We have a partner lined up and it is all dependent on these results? Could this be the domino to fall and we get a quick announcement?
I believe it may be.
In terms of SP movement, it was clear that the leaky ship last week was played. People sold out and now the news is released you will see a more gradual increase in SP. Moving forward the risk/reward ratio just got significantly better. Still risky but the chances of propofol TPM moving to commercialization increased dramatically. The share market will take time to process this announcement.